Share This Post

Progress, Look Ahead in Kidney Cancer Care

From Cure Today:

Expert Highlights Progress, Looks Ahead in Kidney Cancer Care

Over the past few years, therapeutic options for renal cell carcinoma (RCC) have greatly improved, though work still needs to be done in terms of sequencing available agents, according to Mayer Fishman, M.D. There are other challenges that also need to be addressed, says Fishman, such as understanding triggers to therapy and identifying new biomarkers for treatments. Fishman, a medical oncologist at Moffitt Cancer Center, highlighted the most recent advances in the field of RCC during a recent lecture.

Read the full article.

Share This Post

Lost Password


Subscribe for updates!